Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans
Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositiv...
Gespeichert in:
Veröffentlicht in: | The Journal of infectious diseases 1992-05, Vol.165 (5), p.920-924 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 924 |
---|---|
container_issue | 5 |
container_start_page | 920 |
container_title | The Journal of infectious diseases |
container_volume | 165 |
creator | Wiktor, Stefan Z. Cannon, Robert O. Atkinson, William L. Lutz, Brobson Hook, Edward W. Blattner, William A. Quinn, Thomas C. |
description | Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P < .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive. |
doi_str_mv | 10.1093/infdis/165.5.920 |
format | Article |
fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_16843324</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>30112152</jstor_id><sourcerecordid>30112152</sourcerecordid><originalsourceid>FETCH-LOGICAL-c300t-113868f76047261c893814952d800f7951d12999dac8317ed5c1191e99085d853</originalsourceid><addsrcrecordid>eNpFkLFv1DAUhy0EKkdhZ0HyxJarnx079ggH5SKdqAShQl0s4ziqS-IE21F7A_87Kana6Q3f73vDh9BbIFsgip350LU-nYHgW75VlDxDG-CsKoQA9hxtCKG0AKnUS_QqpRtCSMlEdYJOgAvFynKD_tahczb7MeBbn6_xfh5MwA0-HIfpesxxnLzFlz7OCTfHySVcYxNaXNfYB_zd3c2m74-4iSakwefsWvzJJ2eSw7veB2_T_e6j6bMfxuj-u1_dLb6IvVuU1-hFZ_rk3jzcU_Tj_HOz2xeHiy_17sOhsIyQXAAwKWRXCVJWVICVikkoFaetJKSrFIcWqFKqNVYyqFzLLYACpxSRvJWcnaL3698pjn9ml7IefLKu701w45w0CFkyRstlSNahjWNK0XV6in4w8aiB6Pviei2-GFxzvRRflHcPv-dfg2ufhDXxE79JeYyPmBEACpwuvFi5T9ndPXITf2tRsYrr_c8rza4OXDTfzvUl-wf6EpVD</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16843324</pqid></control><display><type>article</type><title>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</title><source>MEDLINE</source><source>JSTOR Archive Collection A-Z Listing</source><creator>Wiktor, Stefan Z. ; Cannon, Robert O. ; Atkinson, William L. ; Lutz, Brobson ; Hook, Edward W. ; Blattner, William A. ; Quinn, Thomas C.</creator><creatorcontrib>Wiktor, Stefan Z. ; Cannon, Robert O. ; Atkinson, William L. ; Lutz, Brobson ; Hook, Edward W. ; Blattner, William A. ; Quinn, Thomas C.</creatorcontrib><description>Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P < .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/165.5.920</identifier><identifier>PMID: 1569344</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Adolescent ; Adult ; Age Factors ; Baltimore - epidemiology ; Concise Communications ; Female ; HIV ; HIV 1 ; HIV Antibodies - blood ; HIV Infections - epidemiology ; HIV-1 - immunology ; HTLV-I Antibodies - blood ; HTLV-I Infections - epidemiology ; HTLV-II Antibodies - blood ; HTLV-II Infections - epidemiology ; Human T lymphotropic virus 1 ; Human T lymphotropic virus 2 ; Humans ; Infections ; Louisiana - epidemiology ; Male ; Male homosexuality ; Men ; Prevalence ; Risk Factors ; Sexually transmitted diseases ; Sexually Transmitted Diseases - epidemiology ; Substance Abuse, Intravenous - complications ; Syphilis ; Viruses</subject><ispartof>The Journal of infectious diseases, 1992-05, Vol.165 (5), p.920-924</ispartof><rights>Copyright 1992 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c300t-113868f76047261c893814952d800f7951d12999dac8317ed5c1191e99085d853</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/30112152$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/30112152$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1569344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wiktor, Stefan Z.</creatorcontrib><creatorcontrib>Cannon, Robert O.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Lutz, Brobson</creatorcontrib><creatorcontrib>Hook, Edward W.</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><creatorcontrib>Quinn, Thomas C.</creatorcontrib><title>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P < .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Baltimore - epidemiology</subject><subject>Concise Communications</subject><subject>Female</subject><subject>HIV</subject><subject>HIV 1</subject><subject>HIV Antibodies - blood</subject><subject>HIV Infections - epidemiology</subject><subject>HIV-1 - immunology</subject><subject>HTLV-I Antibodies - blood</subject><subject>HTLV-I Infections - epidemiology</subject><subject>HTLV-II Antibodies - blood</subject><subject>HTLV-II Infections - epidemiology</subject><subject>Human T lymphotropic virus 1</subject><subject>Human T lymphotropic virus 2</subject><subject>Humans</subject><subject>Infections</subject><subject>Louisiana - epidemiology</subject><subject>Male</subject><subject>Male homosexuality</subject><subject>Men</subject><subject>Prevalence</subject><subject>Risk Factors</subject><subject>Sexually transmitted diseases</subject><subject>Sexually Transmitted Diseases - epidemiology</subject><subject>Substance Abuse, Intravenous - complications</subject><subject>Syphilis</subject><subject>Viruses</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkLFv1DAUhy0EKkdhZ0HyxJarnx079ggH5SKdqAShQl0s4ziqS-IE21F7A_87Kana6Q3f73vDh9BbIFsgip350LU-nYHgW75VlDxDG-CsKoQA9hxtCKG0AKnUS_QqpRtCSMlEdYJOgAvFynKD_tahczb7MeBbn6_xfh5MwA0-HIfpesxxnLzFlz7OCTfHySVcYxNaXNfYB_zd3c2m74-4iSakwefsWvzJJ2eSw7veB2_T_e6j6bMfxuj-u1_dLb6IvVuU1-hFZ_rk3jzcU_Tj_HOz2xeHiy_17sOhsIyQXAAwKWRXCVJWVICVikkoFaetJKSrFIcWqFKqNVYyqFzLLYACpxSRvJWcnaL3698pjn9ml7IefLKu701w45w0CFkyRstlSNahjWNK0XV6in4w8aiB6Pviei2-GFxzvRRflHcPv-dfg2ufhDXxE79JeYyPmBEACpwuvFi5T9ndPXITf2tRsYrr_c8rza4OXDTfzvUl-wf6EpVD</recordid><startdate>199205</startdate><enddate>199205</enddate><creator>Wiktor, Stefan Z.</creator><creator>Cannon, Robert O.</creator><creator>Atkinson, William L.</creator><creator>Lutz, Brobson</creator><creator>Hook, Edward W.</creator><creator>Blattner, William A.</creator><creator>Quinn, Thomas C.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>199205</creationdate><title>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</title><author>Wiktor, Stefan Z. ; Cannon, Robert O. ; Atkinson, William L. ; Lutz, Brobson ; Hook, Edward W. ; Blattner, William A. ; Quinn, Thomas C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c300t-113868f76047261c893814952d800f7951d12999dac8317ed5c1191e99085d853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Baltimore - epidemiology</topic><topic>Concise Communications</topic><topic>Female</topic><topic>HIV</topic><topic>HIV 1</topic><topic>HIV Antibodies - blood</topic><topic>HIV Infections - epidemiology</topic><topic>HIV-1 - immunology</topic><topic>HTLV-I Antibodies - blood</topic><topic>HTLV-I Infections - epidemiology</topic><topic>HTLV-II Antibodies - blood</topic><topic>HTLV-II Infections - epidemiology</topic><topic>Human T lymphotropic virus 1</topic><topic>Human T lymphotropic virus 2</topic><topic>Humans</topic><topic>Infections</topic><topic>Louisiana - epidemiology</topic><topic>Male</topic><topic>Male homosexuality</topic><topic>Men</topic><topic>Prevalence</topic><topic>Risk Factors</topic><topic>Sexually transmitted diseases</topic><topic>Sexually Transmitted Diseases - epidemiology</topic><topic>Substance Abuse, Intravenous - complications</topic><topic>Syphilis</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wiktor, Stefan Z.</creatorcontrib><creatorcontrib>Cannon, Robert O.</creatorcontrib><creatorcontrib>Atkinson, William L.</creatorcontrib><creatorcontrib>Lutz, Brobson</creatorcontrib><creatorcontrib>Hook, Edward W.</creatorcontrib><creatorcontrib>Blattner, William A.</creatorcontrib><creatorcontrib>Quinn, Thomas C.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wiktor, Stefan Z.</au><au>Cannon, Robert O.</au><au>Atkinson, William L.</au><au>Lutz, Brobson</au><au>Hook, Edward W.</au><au>Blattner, William A.</au><au>Quinn, Thomas C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>1992-05</date><risdate>1992</risdate><volume>165</volume><issue>5</issue><spage>920</spage><epage>924</epage><pages>920-924</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><abstract>Patients attending sexually transmitted disease (STD) clinics in Baltimore (n = 4880) and New Orleans (n = 1054) were surveyed in 1987 to estimate the prevalence of human T lymphotropic virus (HTLV)-I/II infection. In Baltimore, 0.4% (95% confidence interval [CI], 0.2–1.1) were HTLV-I/II-seropositive and 4.9% were human immunodeficiency virus (HIV-1)-positive. In New Orleans, 1.8% (CI, 1.2–2.9) of sera were HTLV-I/II-seropositive and 5.1% were HIV-I-seropositive. In both cities, HTLV-I/II prevalence increased significantly with age, and the New Orleans age- and sex-adjusted HTLV-I/II prevalence was significantly higher than that of Baltimore (P < .001). In Baltimore, almost all HTLV-I/II seropositivity was associated with a history of parenteral drug use or sexual contact with partners who were drug users or male homosexuals. In addition, individuals in both cities who were seropositive for HIV-lor syphilis were significantly more likely to be HTLV-I/II-seropositive.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>1569344</pmid><doi>10.1093/infdis/165.5.920</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0022-1899 |
ispartof | The Journal of infectious diseases, 1992-05, Vol.165 (5), p.920-924 |
issn | 0022-1899 1537-6613 |
language | eng |
recordid | cdi_proquest_miscellaneous_16843324 |
source | MEDLINE; JSTOR Archive Collection A-Z Listing |
subjects | Adolescent Adult Age Factors Baltimore - epidemiology Concise Communications Female HIV HIV 1 HIV Antibodies - blood HIV Infections - epidemiology HIV-1 - immunology HTLV-I Antibodies - blood HTLV-I Infections - epidemiology HTLV-II Antibodies - blood HTLV-II Infections - epidemiology Human T lymphotropic virus 1 Human T lymphotropic virus 2 Humans Infections Louisiana - epidemiology Male Male homosexuality Men Prevalence Risk Factors Sexually transmitted diseases Sexually Transmitted Diseases - epidemiology Substance Abuse, Intravenous - complications Syphilis Viruses |
title | Infection with Human T Lymphotropic Virus Types I and II in Sexually Transmitted Disease Clinics in Baltimore and New Orleans |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T06%3A03%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Infection%20with%20Human%20T%20Lymphotropic%20Virus%20Types%20I%20and%20II%20in%20Sexually%20Transmitted%20Disease%20Clinics%20in%20Baltimore%20and%20New%20Orleans&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Wiktor,%20Stefan%20Z.&rft.date=1992-05&rft.volume=165&rft.issue=5&rft.spage=920&rft.epage=924&rft.pages=920-924&rft.issn=0022-1899&rft.eissn=1537-6613&rft_id=info:doi/10.1093/infdis/165.5.920&rft_dat=%3Cjstor_proqu%3E30112152%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16843324&rft_id=info:pmid/1569344&rft_jstor_id=30112152&rfr_iscdi=true |